Zelira Therapeutics Ltd (ASX:ZLD) (OTCMKTS:ZLDAF) has expanded its network in the US by launching its HOPE range of products for autism sufferers in Louisiana, USA, where laws have recently been expanded to allow more patients access to medical marijuana.

With the passage of ACT No 286, all physicians in the State are now allowed to recommend medical marijuana to any of their patients and make such recommendations for any medical condition.

Proactive – Zelira Therapeutics expands US network with Louisiana launch of HOPE products for autism sufferers